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S U M M A R Y 
This publication contains the first series of reports by the Scientific Committee on Cosme-
tology on: 
- the use of chloroform in toothpaste 
- the use of boric acid in cosmetic products 
- the use of 1,1,1-trichloroethane (methylchloroform) in cosmetic products 
- the presence of safrol as an impurity in cosmetic products. 
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INTRODUCTION 
The Scientific Committee on Cosmetology was set up by Commission Decision 78/45/EEC of 
19 December 1977 (OJ N° L 13 of 17 January 1978, p. 24) in order to provide the Commission 
with informed opinions on any scientific and technical problems arising in connection with 
cosmetic products, and in particular on the substances used in their manufacture, on their 
composition and on the conditions for their use. 
The members of the Committee are independent scientists highly qualified in the fields of 
medicine, toxicology, biology, chemistry or other similar disciplines. 
The Committee is serviced by the Environment and Consumer Protection Service. 
This volume contains a collection of the Committee's first reports setting out the opinior 
it delivered on the dates given in the headings. 
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REPORT OF THE SCIENTIFIC COMMITTEE ON COSMETOLOGY 
ON THE 
USE OF CHLOROFORM IN TOOTHPASTE 
(opinion expressed 16 January 1979) 
THE COMMITTEE'S MANDATE 
To give its opinion on the question of whether the use of chloroform in 
toothpaste - in a maximum concentration of A % - is admissable from the 
health point of view. 
CONCLUSION 
The committee recommends that the use of chloroform in toothpastes should 
be discontinued. 
BACKGROUND 
1. Article 5 of Council Directive 76/768/EEC on approximation of the laws 
of the Member States relating to cosmetic products obliges the Member 
States to permit the marketing of toothpaste containing chloroform in 
a maximum concentration of 4 X until 27 July 1979. After that date the 
use of chloroform in making toothpaste will be: 
- permanently authorized; 
- permanently banned/ or 
- permitted for a further three years. 
2. Under Article 12 of the above-mentioned Directive, which empowers 
Member States to prohibit provisionally the marketing in their territory 
of a cosmetic product if they note, on the basis of a statement of 
detailed grounds, that this product, although complying with the require-
ments of the Directive, represents a hazard to health. Several Member 
States have prohibited the marketing of cosmetic products, including 
toothpastes,containing chloroform because of the known toxic effects of 
chloroform. 
3. Consequently, the committee was called on to say whether the use of chlo-
roform in toothpaste in a maximum concentration of 4 % is acceptable 
from the health point of view. 
./. 
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DISCUSSION 
1. The experiments carried out by the National Cancer Institute in the 
USA indicate that, in rats and mice, chloroform fed in high doses 
showed an increased incidence of malignant tumours. 
In both male and female mice, the target organ was the liver whereas in 
male rats there was significant increase in the incidence of renal 
epithelial tumours. 
The Committee concluded this was suggestive of carcinogenic potential. 
However, other long-term experiments with rats, mice and dogs showed 
only renal tumours in ICI mice. 
Further, chloroform is without mutagenic effect on yeasts even after 
enzymatic activation. 
To date, there is no epidemiological data to suggest that chloroform is 
a carcinogen in man. 
Because of these findings the Committee was unable to take 
an unanimous view with respect to the potential carcinogenicity of this 
compound to man. 
2. From the toxicity studies carried out in several animal species, it is 
possible that the margin of safety between the level causing hepato-
toxicity in animals and the possible daily human intake, especially by 
children, is relatively small. 
3. Because of the potential carcinogenicity and the known toxicity of this 
compound, the Committee recommends that the use of chloroform in tooth-
paste be discontinued. 
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REPORT BY THE SCIENTIFIC COMMITTEE ON COSMETOLOGY 
ON THE USE OF BORIC ACID IN COSMETIC PRODUCTS 
(opinion expressed 22 May 1979 
THE COMMITTEE'S MAHDATE 
To give its opinion on the question of whether the restrictions and 
conditions provided for "by Council Directive 76/768/EEC on the use of 
boric acid in cosmetic products are adequate from the public health point 
of view. 
COHCLUSION 
The committee is of the opinion that: 
for talcums the conditions of use and the instructions which must be 
carried on the paokaging should be supplemented by the phrase "not to 
be used on damaged skins"; 
for products for oral hygiene the restrictions and conditions provided 
for by the afore-mentioned Directive are adequate; 
for other products the warning "not to be used on damaged skins" must 
be carried on the packaging. 
BACKGROUND 
1. Article 4 of Council Directive 76/768/EEC on the approximation of the 
laws of the Member States relating to cosmetic products obliges the 
Member States to prohibit the marketing of cosmetic products containing 
substances listed in the first part of Annex III beyond the limits and 
outside the conditions laid down in this Directive. 
2. As regards borio acid, these limits and conditions are: 
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Field of 
application 
and/or use 
Maximum authorized 
concentration in the 
finished cosmetic 
product 
Other limitations 
and requirements 
Conditions of use and 
warnings which 
must be printed 
on the label 
Talos * Not to be used in products for 
children under 
three years old 
Not to be used 
for babies 
Products 
for oral 
hygiene 
0.% 
Other 
products % 
3· Under Article 12 of the same Directive, which enables Member States 
prohibit provisionally the marketing of a oosmetic product in its territory 
or subject it to special conditions, if it notes, on the basis of a 
substantiated justification, that this product, although complying with 
the requirements of the Direotive, represents a hazard to health, a 
Member State has prohibited the manufacture and importing of ail oosmetic 
products containing boric acid and meant to be used for children and 
required that cosmetic products intended for other persons bear a varning 
to the effect that they must not be used for babies* These measures were 
inspired by the high toxioity of borio aoid and the risk of poiioning by 
absorption, particularly through cuts or lesions of the skin (265 cases of 
poisoning have been reported, worldwide)· 
4· Accordingly, the committee was asked to give an opinion of the question 
of whether the restrictions and conditions provided for by 
Council Directive 76/768/EEC were sufficient to safeguard pubiio health. 
DISCUSSION 
5. Clinical experience shows that boric acid represents a toxic hazard, 
especially if it is applied to damaged skin. 
In the case of poisoning ingestion or absorption through the skin, the 
clinical signs consist mainly of gastro-intestinal disorders, skin irrita-
tion and effects on the central nervous system. 
6. Tests on rats and rabbits have shown that when the skin is damaged, the 
quantity of boric acid absorbed depends on the nature of vehicle and on the 
size of the surface treated. 
./., 
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Recent tests on rabbits in Denmark show'that with a specific ointment of 
water in oil the level of urinary excretion/ after application to the 
skin/ is affected neither by skin abrasion nor by the application of an 
occlusive dressing. (Jens SCHOU - mai 1979). 
7. The Committee considers that a pharmacokinetic study of boric acid, 
is the only way to obtain valid information on absorption through the skin/ 
its distribution and excretion. 
8. In babies/ high permeability of the skin/ large areas of exposure 
and wetting by urine are factors increasing percutaneous absorption. 
9. Moreover/ cosmetic products are intended for healthy skins and the 
concentrations used are too close to therapeutic doses. (1) 
10. Consequently/ the Committee recommends/ as a minimum measure/ that: 
(a) for talcs (maximum concentration 5 X) , the warning that must be 
printed on the label should be supplemented by the phrase "not to 
be used on damaged skins"; 
(b) for products for oral hygiene (maximum concentration 0/5 X), the 
restrictions and conditions in Directive 76/768/EEC should not be 
amended; 
(c) for other products (maximum concentration 3 X), the warning "not 
to be used on damaged skins" (21 should be printed on the label. 
11. However/ the Committee would be prepared to review this decision if 
new information on the pharmacokinetics of boric acid and clinical expe-
rience with the babies (in particular blood levels)/ 
were brought to its attention for assessment. 
(1) Some members were of the opinion that boric acid had no therapeutic 
effects. 
(2) One of the members considers that this warning was not justified for 
oily creams (water in oil) containing a maximum of 3 X boric acid. 
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REPORT BY THE SCIENTIFIC COMMITTEE ON COSMETOLOGY CONCERNING THE USE 
OF 1,1,1-TRICHLOROETHANE (METHYLCHLOROFORM) IN COSMETIC PRODUCTS 
(opinion expressed 25 September 1979) 
Terms of reference of the Committee 
To give its opinion on the use of 1/1/1-trichloroethane in cosmetic 
products under the conditions Laid down by Directive 76/768/EEC. 
Conclusion 
The Committee is of the opinion that the use of 1/1/1-trichloroethane in 
cosmetic products/ under the conditions Laid down by Directive 76/768/EEC/ 
can be allowed provisionally for a period of 3 years. 
Background 
1. In accordance with Article 5 of Council Directive 76/768/EEC on the 
approximation of the laws of the Member States relating to cosmetic pro-
ducts/ as amended by Directive 79/661/EEC/ the Member States are to per-
mit - until 31 December 1980 - the marketing of cosmetic products con-
taining 1/1/1-trichloroethane (methylchloroform) subject to the follow-
ing restrictions and conditions: 
(a) field of application and/or use: solvent for aerosol dispensers; 
(b) maximum authorized concentration in the finished cosmetic product: 
35 X. When mixed with dichloromethane, total concentration must 
not exceed 35 %; 
(c) conditions of use and warnings which must be printed on the label: 
do not spray on naked flame or any incandescent material. 
2. On expiry of this time-limit/ the substance shall be: 
- either definitively permitted/ or 
- definitively prohibited (Annex ID/ or 
- retained for a further period of three years in Annex IM, or 
- deleted from all Annexes to the above mentioned Directive. 
3. Accordingly/ the Committee has been asked to give an opinion on the 
use of 1/1/1-trichloroethane (methylchloroform) in cosmetic products 
under the conditions laid down by Directive 76/768/EEC. 
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DISCUSSION 
4. - 1,1,1-trichloroethane contains stabilizers intended to inhibit any 
oxidation or decomposition by light and corrosion inhibitors. These 
substances may present a risk of toxicity and it is essential to know 
the degree of purity of the trichloroethane used in cosmetics, with 
details of the chemical nature, concentration and toxicity of the 
stabilizer(s). 
5. - It mustbe borne in mind that 1,1,1-trichloroethane must be used in concen-
trations of up to 35 % in aerosols. The Committee has considered the 
relative safety of this substance for man in comparison to the most 
widely used propellant gases. 
- Acute inhalation studies indicate that 1,1,1-trichloroethane 
is more toxic than many halogen compounds used in aerosols (cardio-
toxicity in primated). 
- Concentrations inducing loss of coordination and anaesthesia in man 
can be obtained by use in a confined and poorly ventilated space. This 
phenomenon is, however, reversible. 
6. - Long-term tests involving forcible feeding of rodents have given no 
indication of carcinogenicity but the short life span of the animals 
treated does not allow useful conclusions to be drawn from this 
research. 
- No positive response has been observed in teratogenic research on rats 
and mice by inhalation. 
- Long-term tests by inhalation on mice have shown that this substance 
is less toxic than chloroform (hepatic injury). 
- 99 % of the product injected intraperitoneally in rats is eliminated 
unchanged by exhalation and no accumulation in the tissues is observed. 
./. 
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7. - The Committee is of the opinion that the provisional authorization 
of 1,1,1-trichloroethane should be extended for three years. In the 
meantime it wishes to obtain information on: 
(1) the stabilizers used/ their concentration and toxicity; 
(2) the level of exposure in bathrooms and hairdressing saloons; 
(3) the relative toxicity of 1,1,1-trichloroethane compared to common-
ly used freons, in particular as regards acute and subacute toxi-
city by inhalation; 
(A) any epidemiological data that may be available. 
If no such information exists, it will require studies carried 
out on: 
(1) the 90-day toxicity of pure 1,1,1-trichloroethane on rats; 
(2) the long-term toxicity by inhalation on animals (carcinogenicity). 
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REPORT BY THE SCIENTIFIC COMMITTEE ON COSMETOLOGY 
CONCERNING 
THE PRESENCE OF SAFROL AS AN IMPURITY IN COSMETIC PRODUCTS 
(opinion expressed 2 September 1980) 
THE COMMITTEE'S TERMS OF REFERENCE 
To give its opinion on whether, from the public-health point of view, a 
safrol content not exceeding 100 ppm is acceptable as a contaminant in a 
finished cosmetic product. 
CONCLUSION 
It is the Committee's opinion that a safrol content not exceeding 100 ppm is 
acceptable as a contaminant in a finished cosmetic product. 
BACKGROUND 
1. Article 5 of Directive 76/768/EEC on the approximation of the laws of the 
Member States relating to cosmetic products provides that, until 27 July 
1979, Member States shall permit the marketing of cosmetic products con-
taining safrol in a concentration not exceeding 100 ppm. On expiry of that 
time limit this substance shall: 
- either be definitively permitted 
- or definitively prohibited, 
- or retained for a further period of three years. 
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2. Article 12 of the above mentioned directive allows a Member State provi-
sionally to prohibit the marketing of a cosmetic product in its territory, 
or to make it subject to special conditions, "if it notes, on the basis 
of a substantiated justification, that, although complying with the 
requirements of the directive, the product represents a hazard to health". 
In implementation of that Article, one Member State has restricted the 
use of safrol by prohibiting the direct incorporation of the substance in 
cosmetic products on the grounds that, when administered orally to rats 
and mice, safrol has proved to be carcinogenic. 
3. Nevertheless, safrol is a natural contaminant in certain essential oils used 
in the preparation of cosmetic products. 
4. Accordingly, the Committee is requested to deliver an opinion on whether, 
from the point of view of public-health protection, a safrol content not 
exceeding 100 ppm can be accepted as a contaminant in a finished cosmetic 
product. 
DISCUSSION 
5. Studies carried out in the USA on the chronic toxicity of safrol added to 
the feed of rodents have shown that safrol is slightly hepatocarcinogenic 
in the rat and that the liver damage varies according to the sex, age and 
diet of the animal. 
6. The results of the mutagenicity tests are not conclusive. 
7. Safrol is not electrophilie . It interferes with the microsomial enzymes 
of the liver, and in some species is capable of stimulating its own meta-
bolism. 
8. Among the metabolites of safrol demonstrated in rodents' urine I'-hydro-
xysafrol proved more carcinogenic than safrol. The other metabolism rpo-
ducts are 1,2 dihydroxy-A allyl benzene, safrol epoxide and diols formed 
along the epoxide route. 
./. 
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9. Recent research carried out to compare the absorption/ 
metabolism and excretion of safrol in the rat and in man have shown an 
apparent absence of the carcinogenic 1'-hydroxysafrol and its isomer 
3'-hydroxysafroi as metabolites in man. It has not, however, been deter-
mined whether this absence is due to a difference of metabolism or whether 
it depends on the dose administered. 
10. The Committee has decided that a maximum content of 100 ppm of safrol is 
acceptable as a technological residue in the finished cosmetic product in 
view of: 
a) the apparent absence of the carcinogenic metabolite, 1'-hydroxysafrol, 
in man; 
b)the absence of any significant carcinogenic effect at a safrol concen-
tration not exceeding 100 ppm during chronic toxicity tests by oral 
route on the rat; 
c)the fact that the safrol doses absorbed by man through the use of cos-
metics are low and are in no case comparable with those used in meta-
bolic studies on animals (see para. 9). 
11. Nevertheless, the Committee reserves the right to review its decision 
in the light of any new information concerning the possible investiga-
tion in man of a metabolic route observed in rodents, namely the forma-
tion of carcinogenic epoxides. 
12. Nevertheless, the Committee recommends that the presence of safrol be 
avoided in toothpase specifically intended for children. 
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